Return
Company Page
Vivid Dx
Founders
Vivid Dx is a precision diagnostics company and University of Oxford spinout developing a next-generation direct-from-blood platform that combines Raman spectroscopy, a proprietary spectral database, and advanced AI/ML to rapidly identify sepsis-causing pathogens and guide antibiotic treatment decisions. The platform aims to compress diagnostic timelines from days to hours, addressing the global threat of antimicrobial resistance and sepsis, which causes 11 million deaths annually.
Company Founded in 2022
Healthtech & Biotech